Cargando…
Fractionated palliative thoracic radiotherapy in non-small cell lung cancer – futile or worth-while?
BACKGROUND: Palliative thoracic radiotherapy (PTR) can relieve symptoms originating from intra-thoracic disease. The optimal timing and fractionation of PTR is unknown. Time to effect is 2 months. The primary aim of this retrospective study was to investigate survival after PTR, hypothesizing that a...
Autores principales: | Støchkel Frank, Malene, Schou Nørøxe, Dorte, Nygård, Lotte, Fredberg Persson, Gitte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756366/ https://www.ncbi.nlm.nih.gov/pubmed/29304789 http://dx.doi.org/10.1186/s12904-017-0270-4 |
Ejemplares similares
-
Reduction of oesophageal toxicity with VMAT dose-sparing radiotherapy in thoracic metastatic spinal cord compression: A feasibility study
por: Gram, Vanja Remberg, et al.
Publicado: (2022) -
Different fractionation regimes in palliative thoracic radiotherapy: Some facets
por: Sharma, Mukesh, et al.
Publicado: (2015) -
Consumptive Sanatoria: Are They Worth While?
por: Lawson, David
Publicado: (1908) -
Is It Worth While to Try to Save the Teeth?
por: Hopkins, Samuel A.
Publicado: (1902) -
Hallmarks of glioblastoma: a systematic review
por: Nørøxe, Dorte Schou, et al.
Publicado: (2017)